Global Bioactive Bone Grafts Market Size To Exceed USD 8.12 Million By 2035 | CAGR of 3.44%
Category: HealthcareGlobal Bioactive Bone Grafts Market Size To Exceed USD 8.12 Million By 2035
According to a research report published by Spherical Insights & Consulting, The Global Bioactive Bone Grafts Market Size was worth around USD 5.60 Million 2024, growing to 5.75 Million in 2025, and is predicted to grow to around USD 8.12 million by 2035 with a compound annual growth rate (CAGR) of 3.44% from 2025 to 2035.
Get more details on this report -
Browse 210 Market Data Tables And 45 Figures Spread Through 190 Pages and In-Depth TOC On the "Global Bioactive Bone Grafts Market Size, Share, and COVID-19 Impact Analysis, By Product Type (Putty based, Prefilled, and Others), By Application (Dental, Cranio-maxilofacial, Foot and Ankle, Joint Reconstruction, and Others), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035." Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/bioactive-bone-grafts-market
The manufacturing, marketing, and distribution of bioactive bone graft materials which are mostly utilized in orthopedic and dental procedures to promote bone regeneration and repair are all included in the bioactive bone grafts market. These grafts are made of biologically active materials that encourage osteointegration and induce the formation of new bone, such as calcium phosphates, bioactive glass, and ceramics. The bioactive bone grafts market offers a range of product types, including putty, granules, and prefilled segments, to meet the needs of various clinical applications, such as joint reconstruction, foot and ankle, and cranio-maxillofacial surgeries. Rising rates of bone-related illnesses, improvements in biomaterials, an increase in surgical procedures, and greater knowledge of less invasive treatment options are all factors propelling this bioactive bone grafts market's growth. Increased prevalence of orthopedic disorders, developments in bioengineering, and increased knowledge of the advantages of bioactive bone grafts over conventional bone grafts are among the primary factors of this strong expansion. The growing incidence of orthopedic disorders and bone-related diseases such as osteoarthritis, osteoporosis, and bone fractures is one of the main factors propelling the market for bioactive bone grafts. However, the market for bioactive bone grafts is restricted by several important factors, such as the high expense, strict restrictions, lack of awareness, and possibility of immunological rejection.
The putty based segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period.
Based on the product types, the bioactive bone grafts market is divided into putty-based, prefilled, and others. Among these, the putty-based segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period. Putty-based grafts' compatibility with less invasive surgical techniques has aided in their quick uptake as medical facilities look for ways to streamline procedures and lower post-operative complications.
The dental segment accounted for the largest share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period.
Based on the application, the bioactive bone grafts market is divided into dental, cranio-maxilofacial, foot and ankle, joint reconstruction, and others. Among these, the dental segment accounted for the largest share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. Growing availability to specialized dental treatment in both urban and semi-urban areas, along with growing awareness of oral health, has supported market expansion. The dental application market is growing as the need for bone regeneration techniques, sinus lifts, and dental implants increases.
North America is expected to hold the majority share of the global bioactive bone grafts market during the forecast period.
Get more details on this report -
North America is expected to hold the majority share of the global bioactive bone grafts market during the forecast period. North America is recognized for its substantial investments in R&D, high adoption rates of cutting-edge medical innovations, and well-established healthcare infrastructure. Furthermore, it is anticipated that the growing awareness and accessibility of bioactive bone graft products, together with the rising prevalence of orthopedic and dental problems, will propel the market's sustained expansion in North America.
Asia Pacific is anticipated to grow at the fastest pace in the global bioactive bone grafts market during the forecast period. The growing prevalence of orthopedic disorders, rising healthcare investments, expanding medical infrastructure, and increased awareness of sophisticated treatment alternatives are the main drivers of the Asia Pacific region. The region's sizable patient base and expanding availability of cutting-edge bone graft technology also greatly support market expansion.
Major vendors in the global bioactive bone grafts market are NuVasive Inc., Medtronic Plc, Stryker Corporation, Dentsply Sirona Inc., Smith & Nephew Plc, Geistlich Pharma AG, Orthofix Holdings Inc., Kuros Biosciences AG, NovaBone Products LLC, Baxter International Inc., RTI Surgical Holdings Inc., Wright Medical Group N.V., Botiss Biomaterials GmbH, Zimmer Biomet Holdings Inc., and others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Recent Development
- In May 2024, The U.S. Food and Drug Administration (FDA) has granted Irvine-based Biogennix, LLC 510(k) clearance for an additional indication for its Agilon Moldable and Morpheus Moldable bone grafting products. Utilizing an FDA-approved intervertebral body fusion device in conjunction with a bone void filler, the new clearance permits the goods to be employed as autograft extenders in the intervertebral disc space.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the bioactive bone grafts market based on the below-mentioned segments:
Global Bioactive Bone Grafts Market, By Product Type
- Putty based
- Prefilled
- Others
Global Bioactive Bone Grafts Market, By Application
- Dental
- Cranio-maxilofacial
- Foot and Ankle
- Joint Reconstruction
- Others
Global Bioactive Bone Grafts Market, By Regional Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?